Wireless Capsule Endoscopy

Wireless Capsule Endoscopy Market Outlook

The global wireless capsule endoscopy market is projected to reach approximately USD 1.74 billion by 2035, growing at a robust CAGR of 9.7% from 2025 to 2035. This significant growth can be attributed to the increasing prevalence of gastrointestinal disorders, coupled with advancements in capsule technology that enhance diagnostic capabilities. Furthermore, the rising demand for minimally invasive procedures is driving the adoption of wireless capsule endoscopy, as it offers a patient-friendly alternative to traditional endoscopy. The expansion of healthcare infrastructure and increased healthcare spending in emerging markets are also contributing factors to this market growth. Additionally, the ongoing research and development in capsule design and functionality are bolstering the market's trajectory, making wireless capsule endoscopy an increasingly vital tool in gastrointestinal diagnostics.

Growth Factor of the Market

One of the primary growth factors for the wireless capsule endoscopy market is the increasing incidence of gastrointestinal diseases such as inflammatory bowel disease (IBD) and colorectal cancer. These conditions necessitate effective visualization and diagnosis, which wireless capsule endoscopy provides through its non-invasive and highly accurate imaging capabilities. Moreover, the technological advancements in capsule design, including enhanced battery life, improved image resolution, and real-time data transmission, are making these devices more attractive to both healthcare professionals and patients. The rising geriatric population, particularly in developed regions, is also a significant contributor to market growth, as older adults are at a higher risk for gastrointestinal disorders. Additionally, the shift towards outpatient services and the availability of reimbursement policies for endoscopic procedures are fostering market expansion. Education and awareness campaigns about the benefits of capsule endoscopy are further driving adoption among healthcare practitioners.

Key Highlights of the Market

• Projected growth to USD 1.74 billion by 2035 with a CAGR of 9.7%.
• Rising prevalence of gastrointestinal diseases driving market demand.
• Technological advancements enhancing capsule functions and accuracy.
• Growing geriatric population contributing to increased healthcare needs.
• Continuous development of reimbursement policies aiding market expansion.

By Product Type

Small Bowel Capsule Endoscopy:

The small bowel capsule endoscopy segment is a significant part of the wireless capsule endoscopy market, primarily because it addresses one of the most challenging areas of gastrointestinal diagnostics. This type of capsule is specifically designed to visualize the small intestine, which is often difficult to reach with traditional endoscopy methods. The increasing incidence of small intestinal disorders, such as Crohn's disease and obscure gastrointestinal bleeding, is driving the demand for small bowel capsule endoscopy. The non-invasive nature of the procedure allows for greater patient comfort and compliance, which is essential for effective treatment and diagnosis. Furthermore, advancements in imaging technology have improved the clarity and detail of the visuals captured, leading to better diagnostic outcomes. As healthcare providers increasingly recognize the value of this diagnostic tool, the market for small bowel capsules is expected to grow significantly.

Colon Capsule Endoscopy:

Colon capsule endoscopy is rapidly gaining traction within the wireless capsule endoscopy market as it offers a less invasive alternative to traditional colonoscopy. This product type allows for complete visualization of the colon and is especially beneficial for patients who may be at risk for colorectal cancer or those who are unable to undergo conventional procedures due to various medical conditions. The increasing awareness and screening for colorectal cancer, coupled with a growing preference for minimally invasive diagnostic methods, have fueled the adoption of colon capsule endoscopy. Additionally, innovations within this segment, such as improved capsule design and enhanced imaging technology, are elevating its efficacy in detecting polyps and tumors in the colon, further driving market growth. Overall, the colon capsule endoscopy segment is expected to see considerable growth as more healthcare facilities incorporate this technology into their diagnostic offerings.

Oesophageal Capsule Endoscopy:

Oesophageal capsule endoscopy is an emerging segment within the wireless capsule endoscopy market that is garnering interest due to its unique ability to visualize the esophagus non-invasively. This product type is particularly useful for patients experiencing symptoms that may indicate esophageal disorders, such as dysphagia or gastroesophageal reflux disease (GERD). The ability to visualize the esophagus significantly aids in the early detection of conditions like esophageal cancer and Barrett's esophagus. As awareness of esophageal health grows and healthcare providers seek effective diagnostic tools, the adoption of oesophageal capsule endoscopy is anticipated to rise. Furthermore, continuous improvements in capsule technology are enabling better imaging capabilities and patient comfort, creating a favorable market environment. Thus, this segment is poised for growth as more clinical applications are explored and validated.

Others:

The 'Others' category in the product type segment encompasses various innovative capsule designs developed for specific diagnostic purposes beyond the common three categories. These may include capsules tailored for targeted regions or specific conditions, such as detection of gastrointestinal motility disorders or other rare conditions. The inclusion of these advanced technologies is essential for addressing the diverse needs within gastrointestinal diagnostics. As the medical community recognizes the significance of personalized medicine and precision diagnostics, this segment is likely to attract increased investment for research and development. Consequently, the growth of this segment may parallel advances in technology that enable better and more targeted gastrointestinal evaluations, further driving the wireless capsule endoscopy market.

By Application

Gastrointestinal Bleeding:

The application of wireless capsule endoscopy in diagnosing gastrointestinal bleeding is one of the most critical areas driving the market. This procedure allows healthcare providers to visualize the entire gastrointestinal tract, which is essential for accurately identifying the source of bleeding, whether it be from lesions, tumors, or other abnormalities. The non-invasive nature of capsule endoscopy improves patient compliance and reduces the risks associated with traditional endoscopic procedures. As awareness of gastrointestinal bleeding increases and more patients present with these symptoms, the demand for capsule endoscopy as a diagnostic tool is expected to rise significantly. Moreover, advancements in imaging technology are providing clearer and more detailed images, enhancing diagnostic accuracy and leading to timely interventions for patients. Consequently, this segment is poised for considerable growth as more healthcare facilities integrate capsule endoscopy into their diagnostic protocols.

Crohn's Disease:

Wireless capsule endoscopy has become an invaluable tool in the diagnosis and management of Crohn's disease, a chronic inflammatory condition that affects the gastrointestinal tract. The ability to visualize the small intestine, where Crohn's is often most prevalent, enables healthcare providers to assess disease severity and monitor treatment efficacy effectively. As the prevalence of Crohn's disease continues to rise globally, driven by factors such as environmental influences and genetic predisposition, the demand for advanced diagnostic tools like capsule endoscopy is expected to increase. This non-invasive method of visualizing the gastrointestinal tract offers significant advantages, including enhanced patient comfort and reduced procedural risks. Furthermore, ongoing research into the long-term benefits of capsule endoscopy in managing Crohn's disease will likely support continued growth in this application segment.

Small Intestine Tumors:

Detecting small intestine tumors is a crucial application of wireless capsule endoscopy, as traditional diagnostic methods can often miss lesions in this area. The ability of capsule endoscopy to provide comprehensive imaging of the small intestine enables early detection and diagnosis of tumors, which is critical for effective treatment outcomes. As the incidence of small intestine tumors continues to rise, driven by factors such as dietary habits and genetic predisposition, the market for capsule endoscopy in this application is expected to grow. Moreover, the increasing emphasis on preventive healthcare and early intervention strategies is enhancing the appeal of this diagnostic tool among healthcare providers. With ongoing advancements in capsule technology aimed at improving imaging quality and expanding diagnostic capabilities, this segment will likely see significant growth in the coming years.

Others:

In addition to the primary applications mentioned above, the 'Others' category encompasses various other conditions that wireless capsule endoscopy can help diagnose. These may include obscure gastrointestinal bleeding, malabsorption syndromes, and various motility disorders. The versatility of capsule endoscopy in enabling visualization of hard-to-reach areas within the gastrointestinal tract makes it a valuable tool for a wide range of diagnostic scenarios. As more healthcare providers recognize the broad applications of capsule endoscopy, the demand for this innovative diagnostic tool will likely expand. Additionally, ongoing research into new applications and clinical validation will foster further growth within this segment. As a result, the 'Others' application category is poised for significant development as the market evolves and more healthcare professionals adopt this technology.

By End User

Hospitals:

Hospitals are one of the primary end users of wireless capsule endoscopy technology, as they often serve as the first point of care for patients presenting with gastrointestinal symptoms. The integration of capsule endoscopy into hospital settings has been facilitated by its non-invasive nature, which substantially enhances the patient experience compared to traditional endoscopy. Moreover, the ability to conduct detailed evaluations of the gastrointestinal tract using capsule endoscopy allows hospitals to improve diagnostic accuracy and patient outcomes significantly. As hospitals continue to adopt advanced technologies to enhance patient care, the demand for wireless capsule endoscopy is projected to increase. Additionally, hospitals' ongoing investments in advanced imaging technologies and growing emphasis on minimally invasive procedures are further propelling the market growth within this end user segment.

Clinics:

Clinics are increasingly adopting wireless capsule endoscopy technology, driven by patient demand for less invasive diagnostic options and the need for efficient diagnostic services. As clinics strive to provide comprehensive gastrointestinal evaluations, the implementation of capsule endoscopy allows them to streamline their diagnostic processes and enhance patient satisfaction. The ease of use and portability of capsule endoscopy systems make them an ideal choice for outpatient settings, where quick turnaround times are essential. Moreover, the growing awareness of gastrointestinal health and the benefits of early diagnosis are motivating clinics to incorporate this technology into their practices. This trend is likely to continue, as more clinics recognize the value of capsule endoscopy in providing high-quality care and improving patient outcomes.

Diagnostic Centers:

Diagnostic centers represent a significant end user segment for wireless capsule endoscopy, as these facilities are focused on providing specialized diagnostic services. The increasing demand for non-invasive diagnostic procedures is driving the adoption of capsule endoscopy in diagnostic centers, allowing them to offer patients advanced imaging capabilities. With the rise in gastrointestinal disorders and the necessity for accurate diagnostic modalities, diagnostic centers are actively seeking innovative technologies to enhance their service offerings. Capsule endoscopy provides diagnostic centers with the ability to perform comprehensive evaluations of the gastrointestinal tract, which is essential for timely and accurate diagnoses. As the market for gastrointestinal diagnostics continues to expand, the role of diagnostic centers in utilizing wireless capsule endoscopy technology is expected to grow significantly.

Others:

The 'Others' category in the end user segment includes various healthcare facilities and providers that utilize wireless capsule endoscopy technology for diagnostic purposes. This may encompass research institutions, outpatient surgical centers, and specialized gastroenterology practices. As the importance of accurate gastrointestinal diagnostics becomes more recognized across various healthcare settings, the adoption of capsule endoscopy technology is likely to increase. Furthermore, as advancements in capsule design and functionality continue, these facilities may find new applications for this technology that enhance their diagnostic capabilities. The 'Others' segment thus represents a diverse and expanding area within the wireless capsule endoscopy market as healthcare providers seek innovative solutions for gastrointestinal evaluations.

By Region

The North American region is anticipated to dominate the wireless capsule endoscopy market, accounting for approximately 40% of the overall market share by 2035. This growth can be attributed to several factors, including a high prevalence of gastrointestinal disorders, advanced healthcare infrastructure, and a strong emphasis on research and development in medical technologies. The United States, in particular, is witnessing a growing acceptance of wireless capsule endoscopy among healthcare professionals and patients, driven by an increasing awareness of the benefits of non-invasive procedures. Furthermore, the presence of leading manufacturers in the region fosters innovation and competition, further propelling market growth. The CAGR for the North American market is projected to be around 10% during the forecast period, reflecting the region's robust demand for advanced gastrointestinal diagnostics.

In Europe, the wireless capsule endoscopy market is also expected to experience significant growth, with projections indicating a market share of approximately 30% by 2035. The increasing incidence of gastrointestinal diseases and the growing demand for minimally invasive diagnostic procedures are key drivers of this growth. European countries are increasingly investing in healthcare technologies, with healthcare providers adopting wireless capsule endoscopy to enhance patient care. Countries such as Germany, France, and the UK are leading the way in embracing novel diagnostic methods, contributing to the region's overall growth. The CAGR for the European market is anticipated to be around 9.5%, indicating a healthy expansion of wireless capsule endoscopy applications in the region. As awareness and acceptance of this technology continue to rise, Europe will remain a pivotal market for wireless capsule endoscopy.

Opportunities

The wireless capsule endoscopy market presents numerous opportunities for growth, particularly in the realm of technological advancements. As capsule technology continues to evolve, there is significant potential for the development of next-generation capsules equipped with enhanced imaging capabilities, such as 3D imaging and real-time data transmission. Innovations in capsule design can improve diagnostic accuracy and patient comfort, making these devices even more appealing for both healthcare providers and patients. Additionally, expanding the applications of wireless capsule endoscopy to address conditions beyond traditional gastrointestinal disorders offers a lucrative opportunity for market players. Research into the efficacy of capsule endoscopy in detecting rare diseases or conditions can open new avenues for growth and market penetration.

Moreover, the increasing emphasis on preventive healthcare and early diagnosis presents an opportunity for the wireless capsule endoscopy market to expand its reach. As healthcare providers and patients recognize the importance of early detection in improving treatment outcomes, the demand for non-invasive diagnostic solutions will likely continue to rise. New markets, particularly in developing regions, are emerging as healthcare systems evolve and invest in advanced diagnostic technologies. Collaborations and partnerships among manufacturers, healthcare providers, and research institutions can also facilitate the introduction of wireless capsule endoscopy into new geographic markets, further boosting growth. Hence, the combination of technological innovation and a growing focus on preventive healthcare provides a favorable landscape for the wireless capsule endoscopy market.

Threats

The wireless capsule endoscopy market faces several threats that could potentially hinder its growth trajectory. One notable challenge is the high cost associated with capsule endoscopy procedures, which may limit accessibility for patients, particularly in developing regions with constrained healthcare budgets. Additionally, while the technology is advancing, it may still face competition from traditional endoscopic procedures that are well-established and widely accepted in clinical practice. Some healthcare providers may prefer conventional methods due to familiarity and perceived reliability, which could pose challenges for the adoption of wireless capsule endoscopy. Furthermore, regulatory hurdles and the need for extensive clinical validation may slow down the introduction of new capsule technologies and applications.

Another significant threat to the market is the potential for technological malfunctions or failures during capsule procedures. Issues such as capsule retention, where the capsule remains lodged in the gastrointestinal tract, can lead to complications and may deter healthcare providers from adopting this technology. Ensuring patient safety and addressing these concerns through effective training and guidelines is crucial to overcoming this threat. Moreover, the ongoing development of alternative imaging technologies, such as magnetic resonance enterography (MRE) and CT enterography, could pose challenges to the wireless capsule endoscopy market by providing competing options for gastrointestinal imaging. Therefore, addressing these threats will be vital for sustaining market growth and driving acceptance of wireless capsule endoscopy.

Competitor Outlook

• Given Imaging (acquired by Medtronic)
• Medtronic
• Olympus Corporation
• Capsule Technologies
• IntroMedic Co., Ltd.
• Fujifilm Holdings Corporation
• Peerless Medical Technologies, Inc.
• SOMATEX Medical Technologies GmbH
• Chongqing Jinshan Science & Technology Group Co., Ltd.
• Endocapsule Technology Co., Ltd.
• Medigus Ltd.
• VivaLNK, Inc.
• Innovative Health Solutions
• Corindus Vascular Robotics, Inc.
• RSP Health

The competitive landscape of the wireless capsule endoscopy market is characterized by the presence of several key players who are continually striving to innovate and capture market share. Companies such as Medtronic and Olympus Corporation are at the forefront of this market, leveraging their robust research and development capabilities to introduce advanced capsule technologies and enhance procedural efficiency. Both companies have established a strong presence due to their extensive product portfolios and commitment to improving patient outcomes through innovative diagnostic solutions. Ongoing collaborations and partnerships with research institutions further strengthen their market positions, enabling them to stay ahead in this rapidly evolving industry.

Capsule Technologies and Given Imaging, now part of Medtronic, play crucial roles in the wireless capsule endoscopy market by providing cutting-edge capsules designed for various gastrointestinal applications. These companies focus on refining their technologies to improve image clarity and capsule functionality, which is essential for accurate diagnostics. With a strong emphasis on product development and market penetration, they are well-positioned to capitalize on the growing demand for advanced gastrointestinal diagnostic tools. The competitive dynamics in this sector are further influenced by the entry of smaller, innovative companies that are exploring niche applications and specialized capsule designs, creating a diverse and competitive environment.

The landscape of the wireless capsule endoscopy market is also shaped by ongoing advancements in related technologies, such as artificial intelligence and machine learning, which can enhance the diagnostic capabilities of capsule endoscopy. As companies explore integration opportunities with these technologies, they can improve image analysis and decision-making processes, potentially revolutionizing the field of gastrointestinal diagnostics. The competition in this space is expected to intensify, and companies that successfully leverage technology to enhance their offerings will likely gain a competitive advantage in the market. Consequently, the wireless capsule endoscopy market presents a dynamic and evolving competitive landscape that requires continual innovation to meet the diverse needs of healthcare providers and patients alike.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 RSP Health
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medigus Ltd.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 VivaLNK, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Olympus Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Capsule Technologies
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 IntroMedic Co., Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Innovative Health Solutions
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Fujifilm Holdings Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Corindus Vascular Robotics, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Endocapsule Technology Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 SOMATEX Medical Technologies GmbH
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Peerless Medical Technologies, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Given Imaging (acquired by Medtronic)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Chongqing Jinshan Science & Technology Group Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Wireless Capsule Endoscopy Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Diagnostic Centers
    • 6.1.4 Others
  • 6.2 Wireless Capsule Endoscopy Market, By Application
    • 6.2.1 Gastrointestinal Bleeding
    • 6.2.2 Crohn's Disease
    • 6.2.3 Small Intestine Tumors
    • 6.2.4 Others
  • 6.3 Wireless Capsule Endoscopy Market, By Product Type
    • 6.3.1 Small Bowel Capsule Endoscopy
    • 6.3.2 Colon Capsule Endoscopy
    • 6.3.3 Oesophageal Capsule Endoscopy
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Wireless Capsule Endoscopy Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Wireless Capsule Endoscopy market is categorized based on

By Product Type

• Small Bowel Capsule Endoscopy
• Colon Capsule Endoscopy
• Oesophageal Capsule Endoscopy
• Others

By Application

• Gastrointestinal Bleeding
• Crohn's Disease
• Small Intestine Tumors
• Others

By End User

• Hospitals
• Clinics
• Diagnostic Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Given Imaging (acquired by Medtronic)
• Medtronic
• Olympus Corporation
• Capsule Technologies
• IntroMedic Co., Ltd.
• Fujifilm Holdings Corporation
• Peerless Medical Technologies, Inc.
• SOMATEX Medical Technologies GmbH
• Chongqing Jinshan Science & Technology Group Co., Ltd.
• Endocapsule Technology Co., Ltd.
• Medigus Ltd.
• VivaLNK, Inc.
• Innovative Health Solutions
• Corindus Vascular Robotics, Inc.
• RSP Health